Bar Harbor Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Bar Harbor Wealth Management's CRL Position: Q1 2022 in Review
Bar Harbor Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 537 shares — an estimated $202K sold.
Bar Harbor Wealth Management first reported a position in CRL in Q2 2016 and held it in 20 quarters. The position peaked at $493K in Q1 2019. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.
- Bar Harbor Wealth Management reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
- Bar Harbor Wealth Management sold 537 Charles River Laboratories shares in Q1 2022, an estimated $202K.
- Bar Harbor Wealth Management first reported a position in Charles River Laboratories in Q2 2016 and held it in 20 quarters.
- Bar Harbor Wealth Management's Charles River Laboratories position peaked at $493K in Q1 2019.
- 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.
Based on Bar Harbor Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.